Competitive Readiness
Our competitive readiness capabilities have established Deallus as a trusted partner to many of the world’s leading life sciences companies.
Our capability-building, based on the compelling competitor and market insights we unearth, underpins client strategic decision-making, reinforces competitive mindsets and strengthens brand planning processes to enhance competitive readiness across all relevant divisions, functions and geographies.
CI manager training
Integrating competitive intelligence and the management of CI within an organisation
Training the trainer
Developing internal competitive intelligence champions to drive the value of CI throughout the organisation
Building a competitive mindset
Integrating competitive insights into meaningful brand planning
Training field teams
Sales force training centered on developing a competitive mindset and demystifying competitive challenges
Antimicrobial Resistance
Lack of innovation surrounding the development of new antibiotics has resulted in an alarming situation, given the rising threat of antimicrobial resistance (AMR). As a result, there is no single or straightforward way to combat AMR, nor to galvanize development of novel antibiotics. Although some positive measures have been introduced, further - and larger scale - action is needed. We take a look at what pharma and the larger healthcare industry needs to do in order to combat this looming threat.
Deallus Keynote at Pharma CiMi.CON EU 2019
Jonas gives a keynote speech that delves into the importance of strategic intelligence for pharma given today’s dynamic and disruptive marketplace. He explores how competitive and strategic intelligence are related, how to build more strategically focused engagements, and how to help decision makers realize the value in strategic partnerships with their intelligence teams.
Copay Accumulator Programs & Pharma
Dynamics between pharma and the market-based healthcare sector it serves have invariably been complex, with one of the biggest drivers of that complexity being effective management of patient demand and payer systems. The newest stratagem in this push and pull is the copay accumulator program, or CAP. We take a closer look at CAPs and how they might affect your brand in the near future.